Translational Oncology, 2026
SELE is associated with reduced breast cancer susceptibility: Evidence from Mendelian randomization and single-cell transcriptome

Chen H., Hu W., Liu R. et al.

JHEP Reports, 2026
A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action

Rohbeck E., Niersmann C., Dewidar B. et al.

International Journal of Surgery, 2026
Perioperative immune dynamics and infectious complications: a pooled-data analysis of prospective studies

Jacobs L., Bijkerk V., Albers-Warlé K. et al.

Hypertension, 2026
Proteomic Risk Score for Prediction of Incident Hypertension

Kim M., Tavolinejad H., Sarmiento Bustamante M. et al.

iScience, 2026
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress

Assad N., Nordin H., Nguyen A. et al.

iScience, 2026
Plasma protein biomarkers predictive of progression to active tuberculosis among close contacts of patients with tuberculosis

Han Y., Shao Y., Liu Q. et al.

Journal for ImmunoTherapy of Cancer, 2026
CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis

Wang L., Yang G., Lei H. et al.

Pulmonary Circulation, 2026
Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis

Engel Sällberg A., Ahmed S., Ahmed A. et al.

Frontiers in Psychiatry, 2026
Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression

Li Z., Jiao Z., Peng M. et al.

Frontiers in Psychiatry, 2026
Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression

Li Z., Jiao Z., Peng M. et al.

Science Translational Medicine, 2026
AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy

Pannia E., Simonian R., Sabha N. et al.

PROTEOMICS – Clinical Applications, 2026
A Network‐Based Association of IBD and Colorectal Cancer Using Proteomics Data

Dhami J., Radhakrishnan S., Russ D. et al.

The Journal of Maternal-Fetal & Neonatal Medicine, 2026
Causal relationship between 91 inflammatory factors and fetal growth restriction: a bidirectional Mendelian randomization study

Shen J., Chen X., Fang R. et al.

npj Breast Cancer, 2026
Phase II trial of anlotinib-chemotherapy combination in pretreated HER2-negative metastatic breast cancer: therapeutic efficacy and proteomic biomarker profiling

Xu T., Gu Q., Li S. et al.

Alzheimer's & Dementia, 2026
Ethnic‐specific effects of the LILRB2–LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population

Cao H., Zheng Z., Zhou X. et al.

Journal of Advanced Research, 2026
Tocilizumab-loaded nanoparticles block IL-6R and reduce edema after intracerebral hemorrhage

Ma S., Lin Q., Xue D. et al.

Nature Communications, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Hamid O., Ekström-Rydén V., Mehmi I. et al.

Nature Medicine, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders

Bolsewig K., Bellomo G., Hok-A-Hin Y. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2026
A novel diagnostic serum protein signature for pediatric inflammatory bowel disease

Mathisen C., Nyström N., Bazov I. et al.

Journal of Parkinson’s Disease, 2026
A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value

Aviolat H., Mollon J., Giaisi S. et al.